Avestar Capital, LLC Shockwave Medical, Inc. Transaction History

Avestar Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$191.17 - $325.63 $173,964 - $296,323	-910 Reduced 45.68%	1,082 $352,000
Q4 2023 Feb 12, 2024	BUY	$160.99 - $215.69 $284,952 - $381,771	1,770 Added 797.3%	1,992 $379,000
Q3 2023 Oct 20, 2023	SELL	$194.33 - $283.97 $777 - $1,135	-4 Reduced 1.77%	222 $44,000
Q2 2023 Aug 01, 2023	BUY	$223.05 - $302.68 $50,409 - $68,405	226 New	226 $64,000
Q2 2022 Jul 28, 2022	SELL	$115.91 - $214.48 $171,894 - $318,073	-1,483 Reduced 74.49%	508 $97,000
Q1 2022 Apr 26, 2022	BUY	$127.96 - $207.36 $254,768 - $412,853	1,991 New	1,991 $413,000
Q4 2021 Feb 01, 2022	SELL	$165.13 - $241.83 $850,089 - $1.24 Million	-5,148 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$163.99 - $235.57 $844,220 - $1.21 Million	5,148 New	5,148 $1.06 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.